Using nutraceuticals in the management of major depressive disorder (MDD): Approach to be considered for sustainable healthcare systems. Issue 1 (3rd January 2017)

• Record Type: Journal Article
• Authors: Khalifa, Nahlaa; Aljaaly, Elham Abbas
• Is Part Of: World journal of science, technology and sustainable development. Volume 14:Issue 1(2017)
• Page Start: 50
• Page End: 59
• Publication Date: 2017-01-03
• Subjects: 5-hydroxytryptophan (5-HTP) -- Complementary and alternative medicine (CAM) -- Major depressive disorder -- Nutraceuticals -- Omega-3. -- S-adenosyl methionine (SAMe); Sustainable development -- Periodicals; Appropriate technology -- Periodicals; Technology transfer -- Periodicals; Globalization -- Periodicals; 338.92705
• DOI: 10.1108/WJSTSD-01-2016-0007
• Languages: English
• ISSNs: 2042-5945

Abstract

Abstract : Purpose: The purpose of this paper is to study evidence-based records on the impact of some effective nutraceuticals on major depression disorder management; and describe the antidepressant properties of nutraceuticals to achieve health policy targets and maintain a sustainable healthcare system. Design/methodology/approach: The literature was searched using MEDLINE (PubMed), Google Scholar, PsycINFO and Quertile databases and retrieving relevant published articles in peer-reviewed journals. Findings: The results provided evidence of a range of nutraceuticals with potential benefits in the management of depression. Studies support the anti-depressant properties of S-adenosyl methionine, folnic acid, 5-hydroxytryptophan and omega-3 fatty acids. The results might represent evidence for an innovative adjunctive neurobiological line for the management and treatment of depression. Practical implications: Randomized-controlled trials and evaluations continue to provide evidence for the use of nutraceuticals in the treatment of depression. Social implications: Nutraceuticals emphasize the personalized medicine, which offers a psychophysical balance to the individual. Originality/value: Nutraceuticals have specific antidepressant properties that may be beneficial in psychiatric populations and reduce pharmacotherapeutic side effects.